During the past decade, Beijing Tongren Hospital,Cmu conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beijing Tongren Hospital,Cmu" #1 sponsor was "Chengdu Kanghong Biotech Co., Ltd." with 3 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Atos Medical AB" with 1 trials sponsored, "Etern BioPharma (Shanghai) Co., Ltd" with 1 trials sponsored and "Galderma R&D" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beijing Tongren Hospital,Cmu" #1 collaborator was "Beijing Tongren Hospital" with 1 trials as a collaborator, "Eye & ENT Hospital of Fudan University" with 1 trials as a collaborator and "Peking Union Medical College Hospital" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Beijing Tongren Hospital,Cmu" are "Advanced Solid Tumor" (1 trials), "Allergic Rhinitis" (1 trials), "COVID-19" (1 trials), "Chronic Rhinosinusitis (Diagnosis)" (1 trials) and "Laryngectomy; Status" (1 trials). Many other conditions were trialed in "Beijing Tongren Hospital,Cmu" in a lesser frequency.

Most popular intervention types in "Beijing Tongren Hospital,Cmu" are "Drug" (7 trials), "Biological" (4 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Adjuvant" (1 trials), "Bencycloquidium Bromide Nasal Spray" (1 trials), "Budesonide" (1 trials) and "CM310" (1 trials). Other intervention names were less common.

The vast majority of trials in "Beijing Tongren Hospital,Cmu" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Beijing Tongren Hospital,Cmu". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Beijing Tongren Hospital,Cmu, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Beijing Tongren Hospital,Cmu, 4 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".